Skip to main content


HI-TRON Mainz aspires to revolutionize cancer therapy, particularly with personalized approaches turning the patient‘s immune system into a powerful weapon against cancer.

To this end, the founding partners will join forces to build a collaborative translational platform for personalized cancer immunotherapy covering:

   •  Personalized biomarker research
   •  Development of new concepts for immunotherapy
   •  Clinical implementation through clinical translation